The Blame Game
Read More:
New Drugs,
Fda Approval,
Fda,
Walter Armstrong,
Schering-Plough,
Wyeth,
Pharmaceutical Companies,
Approvable Letters,
Pharmaceutical Industry,
Andy Grove,
Government and Pharmaceuticals Industry,
R&D Spending,
Vioxx,
New Drug Applications,
Novartis,
Motley Fool,
Politics News
The FDA is letting potential benefits fall by the wayside by using outdated rigid statistical approaches, contributing to a drop-off in important new drugs being brought to market.
Richard Miller | Posted 12.05.2007 | Politics